Collaborative effort advances next-generation therapies for pancreatic and GI cancers
Last year, researchers at the University of California, Riverside, developed a novel “molecular crowbar” strategy to degrade the oncogenic enzyme…
Unlocking cancer’s secrets: Why whale DNA holds the key; scientists reveal |
The bowhead whale is one of nature’s most remarkable survivors. Living for more than two centuries and weighing…
Hyperthermia correlates with low incidence of radiation pneumonitis after thoracic radiotherapy: a retrospective study | BMC Cancer
Hyperthermia has been extensively utilized in the treatment of malignant tumors [14, 15], however, investigations into its correlation…
The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy | Molecular Cancer
Bernadotte A, Mikhelson VM, Spivak IM. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence.…
Inflammation identified as a key driver in the earliest stages of lung cancer
By creating high-resolution cellular and molecular visual maps of lung cancer before and during development, researchers at The…
UCLA experts call for individualized heart monitoring in breast cancer survivors
As breast cancer survival rates continue to climb – 4.3 million women in the U.S. are currently living…
Lactate and lactylation drive metabolic, epigenetic reprogramming in gynecological cancers
Lactate, once considered a metabolic waste product, is now recognized as a key regulator of cellular homeostasis and…
Context-dependent impact of type I interferon signaling in cancer | Molecular Cancer
Hardy MP, Owczarek CM, Jermiin LS, Ejdebäck M, Hertzog PJ. Characterization of the type I interferon locus and…
Harnessing extracellular vesicles for targeted lung cancer treatment
In the quest for more targeted lung cancer treatments, a researcher at the University of Missouri thinks the…
Mitochondria and lysosomes work together to control regulatory T cell activation
Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the…
The MyCancerGene study: a hybrid type 1 effectiveness-implementation randomized study comparing a patient-centered digital genetic health portal to usual care after receipt of cancer genetic testing | BMC Cancer
Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American society of clinical oncology policy statement update:…
Breakthrough combo therapy lowers death risk in recurrent prostate cancer
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination…